Get the Stockscreener App
38.01
4.45%
1.62
After Hours:
38.10
0.09
+0.24%
Bruker Corp stock is traded at $38.01, with a volume of 2.52M.
It is up +4.45% in the last 24 hours and up +3.40% over the past month.
Bruker Corp manufactures scientific instruments and diagnostic tests for customers in the life sciences, applied markets, pharmaceutical, and biotechnology industries. The company operates in segments, namely, Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Bruker Energy & Supercon Technologies (BEST) . The company generates maximum revenue from the BSI CALID segment. Geographically, it derives the maximum of its revenue from United States.
See More
Previous Close:
$36.39
Open:
$36.53
24h Volume:
2.52M
Relative Volume:
1.17
Market Cap:
$5.79B
Revenue:
$3.44B
Net Income/Loss:
$-8.30M
P/E Ratio:
-255.62
EPS:
-0.1487
Net Cash Flow:
$43.30M
1W Performance:
+4.83%
1M Performance:
+3.40%
6M Performance:
-5.45%
1Y Performance:
-6.68%
1-Day Range:
$36.53
$38.53
1-Week Range:
$33.80
$38.53
52-Week Range:
$28.53
$56.22
Bruker Corp Stock (BRKR) Company Profile
Name
Bruker Corp
Sector
Industry
Phone
978663-3660
Address
40 MANNING RD, BILLERICA, MA
Compare BRKR vs ABT, SYK, MDT, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
BRKR
Bruker Corp
|
38.01 | 5.54B | 3.44B | -8.30M | 43.30M | -0.1487 |
ABT
Abbott Laboratories
|
87.17 | 152.48B | 45.13B | 6.28B | 7.38B | 3.5895 |
SYK
Stryker Corp
|
295.25 | 111.40B | 25.27B | 3.34B | 4.57B | 8.6358 |
MDT
Medtronic Plc
|
77.79 | 100.53B | 35.48B | 4.64B | 5.41B | 3.582 |
BSX
Boston Scientific Corp
|
55.98 | 84.50B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
82.91 | 48.04B | 6.30B | 1.07B | 1.34B | 1.8406 |
Bruker Corp Stock (BRKR) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-10-25 | Upgrade | Wolfe Research | Peer Perform → Outperform |
| Dec-09-25 | Initiated | Goldman | Sell |
| Nov-20-25 | Initiated | Rothschild & Co Redburn | Buy |
| May-22-25 | Downgrade | Citigroup | Buy → Neutral |
| Dec-19-24 | Initiated | Guggenheim | Buy |
| Dec-10-24 | Initiated | UBS | Neutral |
| Dec-05-24 | Upgrade | Goldman | Sell → Neutral |
| Oct-15-24 | Initiated | Barclays | Overweight |
| Sep-30-24 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| Aug-28-24 | Initiated | Wells Fargo | Overweight |
| Jun-03-24 | Resumed | Jefferies | Buy |
| Feb-14-24 | Upgrade | JP Morgan | Neutral → Overweight |
| Dec-19-23 | Initiated | Wells Fargo | Equal Weight |
| Dec-13-23 | Initiated | Wolfe Research | Outperform |
| Oct-21-22 | Initiated | UBS | Buy |
| Aug-22-22 | Upgrade | Citigroup | Neutral → Buy |
| Oct-15-21 | Resumed | Cowen | Market Perform |
| Jun-15-21 | Upgrade | Cleveland Research | Neutral → Buy |
| Feb-05-21 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Dec-02-20 | Initiated | Goldman | Sell |
| Nov-16-20 | Upgrade | Wolfe Research | Underperform → Peer Perform |
| May-01-20 | Downgrade | Cleveland Research | Buy → Neutral |
| Apr-02-20 | Downgrade | Wolfe Research | Peer Perform → Underperform |
| Apr-01-20 | Downgrade | Needham | Strong Buy → Hold |
| Mar-26-20 | Upgrade | Barclays | Equal Weight → Overweight |
| Jan-08-20 | Initiated | Wells Fargo | Overweight |
| Jan-07-20 | Initiated | Citigroup | Buy |
| Nov-15-19 | Initiated | Stifel | Hold |
| Sep-26-19 | Upgrade | BofA/Merrill | Neutral → Buy |
| Jul-15-19 | Upgrade | Goldman | Sell → Neutral |
| Jun-24-19 | Reiterated | Needham | Strong Buy |
| Jun-21-19 | Reiterated | BofA/Merrill | Neutral |
| May-30-19 | Initiated | Wolfe Research | Peer Perform |
| May-06-19 | Reiterated | Needham | Strong Buy |
| May-03-19 | Upgrade | SVB Leerink | Mkt Perform → Outperform |
| May-03-19 | Upgrade | UBS | Sell → Neutral |
| Apr-12-19 | Upgrade | Deutsche Bank | Hold → Buy |
| Feb-12-19 | Reiterated | BTIG Research | Buy |
| Jan-03-19 | Initiated | Needham | Strong Buy |
View All
Bruker Corp Stock (BRKR) Latest News
Bruker earnings on deck as first quarter results loom Wednesday By Investing.com - Investing.com Canada
MSN Money - MSN
Related_a1otxm - MSN
Earnings Preview: Bruker Corp to Report Financial Results Pre-market on May 06 - Moomoo
Bruker Launches High-Throughput Molecular Diagnostic System for Infectious Diseases in Europe - Clinical Lab Products
Bruker Corp (BRKR) Shares Fall 5.4% -- What GF Score of 81 Tells Investors - GuruFocus
Bruker Announces Date and Time of First Quarter 2026 Earnings Release and Webcast - Moomoo
Analysts Estimate Bruker (BRKR) to Report a Decline in Earnings: What to Look Out for - Yahoo Finance
Bruker (BRKR) Expected to Announce Quarterly Earnings on Wednesday - MarketBeat
BRKR Stock Price, Quote & Chart | BRUKER CORP (NASDAQ:BRKR) - ChartMill
Bruker enhances MALDI and IR Biotyper for infection control - SelectScience
Bruker unveils MyGenius PRO diagnostics system - MSN
Bruker Corp | 8-K: Current report - Moomoo
Bruker (NASDAQ: BRKR) sets $3.9844 dividend on 6.375% preferred - Stock Titan
Bruker announces Q2 preliminary revenue between $795M and $798M; shares decline over 3.5% - MSN
Universal Beteiligungs und Servicegesellschaft mbH Sells 135,470 Shares of Bruker Corporation $BRKR - MarketBeat
Bruker Corp. Hits Day Low at $34.88 Amid Price Pressure - Markets Mojo
Bruker Corp (BRKR) Stock Price, Trades & News - GuruFocus
Bruker acquires Austria based biocrates - MSN
Peregrine Capital Management LLC Raises Holdings in Bruker Corporation $BRKR - MarketBeat
Omics-Based Clinical Trials Research Report 2026: $47.78 Bn Market Opportunities, Trends, Competitive Landscape, Strategies, and Forecasts, 2020-2025, 2025-2030F, 2035F - GlobeNewswire Inc.
Bruker Corp (BRKR) Stock Down 8.7% -- Now Undervalued? GF Score: 81/100 - GuruFocus
Bruker (NASDAQ:BRKR) Stock Price Down 8.7%Time to Sell? - MarketBeat
Trending Industry Today: Bruker Corp Leads Losses In Room-Temp Superconductors Stocks - Moomoo
BRKR Financials: Income Statement, Balance Sheet & Cash Flow | Bruker Corp - Stock Titan
Is Bruker (BRKR) Fairly Priced After Recent Short Term Share Price Rebound? - Yahoo Finance
Bruker Corp. Experiences Revision in Stock Evaluation Amid Market Dynamics - Markets Mojo
Bruker Corp. Opens with 6.41% Gain, Marking Significant Gap Up in Stock Performance - Markets Mojo
Bruker Spatial Biology Showcases High Fidelity Spatial Data and Integrated Multi-platform Workflows for Unprecedented Multiomic Insights at AACR 2026 - 富途牛牛
Bruker Corp stock (US1167941087): Is its scientific instruments edge strong enough for steady growth - AD HOC NEWS
Bruker, Amneal, Amphastar Pharmaceuticals, Dentsply Sirona, and PacBio Stocks Trade Up, What You Need To Know - Yahoo Finance
Bruker Launches MyGenius PRO® High-Throughput Sample-to-Answer M - GuruFocus
Bruker (BRKR) Unveils Innovations for Cancer Research at Upcomin - GuruFocus
A Look at Bruker Corp (BRKR) After 4.5% Gain -- GF Value $71.47 vs Price $40.70 - GuruFocus
Bruker unveils spatial biology workflows, opens PaintScape pre-orders By Investing.com - Investing.com Canada
Bruker Launches MyGenius PRO Automated Molecular Diagnostics System in Europe - Contract Pharma
Bruker expands microbiology portfolio with new testing tools By Investing.com - Investing.com South Africa
Bruker unveils spatial biology workflows, opens PaintScape pre-orders - Investing.com
Bruker Spatial Biology Showcases High Fidelity Spatial Data and Integrated Multi-platform Workflows for Unprecedented Multiomic Insights at AACR 2026 – Company AnnouncementFT.com - Financial Times
Bruker expands microbiology portfolio with new testing tools - Investing.com
Bruker launches automated molecular diagnostics system in Europe - Investing.com
Bruker Launches MyGenius PRO® High-Throughput Sample-to-Answer Molecular Diagnostics System at ESCMID 2026 - Bakersfield.com
Bruker Corp Stock (BRKR) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.41%
0.93%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):